-
1
-
-
0033868274
-
Benefits of reducing low-density lipoprotein cholesterol concentrations to <100 mg/dL
-
Schaefer EJ, Brousseau ME. Benefits of reducing low-density lipoprotein cholesterol concentrations to <100 mg/dL. Prev Cardiol 2000;3:136-9.
-
(2000)
Prev Cardiol
, vol.3
, pp. 136-139
-
-
Schaefer, E.J.1
Brousseau, M.E.2
-
2
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4 444 patients with heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
3
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
4
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
5
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFGAPS/TexCAPS
-
Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFGAPS/TexCAPS. JAMA 1998;279:1615-22.
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
6
-
-
0025731272
-
Prevalence of risk factors in men with premature coronary heart disease
-
Genest JJ, McNamara JR, Salem DN, Schaefer EJ. Prevalence of risk factors in men with premature coronary heart disease. Am J Cardiol 1991;67:1185-9.
-
(1991)
Am J Cardiol
, vol.67
, pp. 1185-1189
-
-
Genest, J.J.1
McNamara, J.R.2
Salem, D.N.3
Schaefer, E.J.4
-
7
-
-
0242577955
-
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial
-
Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003;290:2292-300.
-
(2003)
JAMA
, vol.290
, pp. 2292-2300
-
-
Nissen, S.E.1
Tsunoda, T.2
Tuzcu, E.M.3
-
8
-
-
0242493614
-
High-density lipoproteins as an emerging therapeutic target for atherosclerosis
-
Rader DJ. High-density lipoproteins as an emerging therapeutic target for atherosclerosis. JAMA 2003;290:2322-4.
-
(2003)
JAMA
, vol.290
, pp. 2322-2324
-
-
Rader, D.J.1
-
9
-
-
0027275449
-
Plasma cholesteryl ester transfer protein
-
Tall AR, Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-74.
-
(1993)
J Lipid Res
, vol.34
, pp. 1255-1274
-
-
Tall, A.R.1
-
10
-
-
0024415898
-
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
-
Brown ML, Inazu A, Hesler CB, et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989;342:448-51.
-
(1989)
Nature
, vol.342
, pp. 448-451
-
-
Brown, M.L.1
Inazu, A.2
Hesler, C.B.3
-
11
-
-
0022346576
-
Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia
-
Koizumi J, Mabuchi H, Yoshimura A, et al. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 1985;58:175-86.
-
(1985)
Atherosclerosis
, vol.58
, pp. 175-186
-
-
Koizumi, J.1
Mabuchi, H.2
Yoshimura, A.3
-
12
-
-
0025104275
-
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
-
Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990;323:1234-8.
-
(1990)
N Engl J Med
, vol.323
, pp. 1234-1238
-
-
Inazu, A.1
Brown, M.L.2
Hesler, C.B.3
-
13
-
-
0024321774
-
Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism
-
Whitlock ME, Swenson TL, Ramakrishnan R, et al. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit: effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest 1989;84:129-37.
-
(1989)
J Clin Invest
, vol.84
, pp. 129-137
-
-
Whitlock, M.E.1
Swenson, T.L.2
Ramakrishnan, R.3
-
14
-
-
0028061579
-
Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition
-
Gaynor BJ, Sand T, Clark RW, Aiello RJ, Bamberger MJ, Moberly JB. Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis 1994;110:101-9.
-
(1994)
Atherosclerosis
, vol.110
, pp. 101-109
-
-
Gaynor, B.J.1
Sand, T.2
Clark, R.W.3
Aiello, R.J.4
Bamberger, M.J.5
Moberly, J.B.6
-
15
-
-
0029762060
-
Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits
-
Sugano M, Makino N. Changes in plasma lipoprotein cholesterol levels by antisense oligodeoxynucleotides against cholesteryl ester transfer protein in cholesterol-fed rabbits. J Biol Chem 1996;271:19080-3.
-
(1996)
J Biol Chem
, vol.271
, pp. 19080-19083
-
-
Sugano, M.1
Makino, N.2
-
16
-
-
0032570684
-
Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits
-
Sugano M, Makino N, Sawada S, et al. Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 1998;273:5033-6.
-
(1998)
J Biol Chem
, vol.273
, pp. 5033-5036
-
-
Sugano, M.1
Makino, N.2
Sawada, S.3
-
17
-
-
0034644214
-
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
-
Okatnoto H, Yonemori F, Wakitani K, Minowa T, Maeda K, Shinkai H. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature 2000;406:203-7.
-
(2000)
Nature
, vol.406
, pp. 203-207
-
-
Okatnoto, H.1
Yonemori, F.2
Wakitani, K.3
Minowa, T.4
Maeda, K.5
Shinkai, H.6
-
18
-
-
0031043174
-
Inhibition of cholesteryl ester transfer protein by CGS 25159 and changes in lipoproteins in hamsters
-
Kothari HV, Poirier KJ, Lee WH, Satoh Y. Inhibition of cholesteryl ester transfer protein by CGS 25159 and changes in lipoproteins in hamsters. Atherosclerosis 1997;128:59-66.
-
(1997)
Atherosclerosis
, vol.128
, pp. 59-66
-
-
Kothari, H.V.1
Poirier, K.J.2
Lee, W.H.3
Satoh, Y.4
-
19
-
-
0033822810
-
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis
-
Rittershaus CW, Miller DP, Thomas LJ, et al. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2106-12.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 2106-2112
-
-
Rittershaus, C.W.1
Miller, D.P.2
Thomas, L.J.3
-
20
-
-
0037035459
-
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: A randomized phase II dose-response study
-
de Grooth GJ, Kuivenhoven JA, Stalenhoef AFH, et al. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 2002;105:2159-65.
-
(2002)
Circulation
, vol.105
, pp. 2159-2165
-
-
De Grooth, G.J.1
Kuivenhoven, J.A.2
Stalenhoef, A.F.H.3
-
21
-
-
0023221817
-
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
-
McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8.
-
(1987)
Clin Chim Acta
, vol.166
, pp. 1-8
-
-
McNamara, J.R.1
Schaefer, E.J.2
-
22
-
-
0028909026
-
Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated
-
McNamara JR, Cole TG, Contois JH, Ferguson CA, Ordovas JM, Schaefer EJ. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem 1995;41:232-40.
-
(1995)
Clin Chem
, vol.41
, pp. 232-240
-
-
McNamara, J.R.1
Cole, T.G.2
Contois, J.H.3
Ferguson, C.A.4
Ordovas, J.M.5
Schaefer, E.J.6
-
23
-
-
0020004724
-
Dextran sulfate-Mg2+ precipitation procedure fot quantitation of high-density-lipoprotein cholesterol
-
Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure fot quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
-
(1982)
Clin Chem
, vol.28
, pp. 1379-1388
-
-
Warnick, G.R.1
Benderson, J.2
Albers, J.J.3
-
24
-
-
0000348427
-
Improved methods for separation of total HDL and subclasses
-
abstract
-
Nguyen T, Warnick GR. Improved methods for separation of total HDL and subclasses. Clin Chem 1989;35:1086. abstract.
-
(1989)
Clin Chem
, vol.35
, pp. 1086
-
-
Nguyen, T.1
Warnick, G.R.2
-
25
-
-
0026644250
-
Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
-
Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992;38:1632-8.
-
(1992)
Clin Chem
, vol.38
, pp. 1632-1638
-
-
Otvos, J.D.1
Jeyarajah, E.J.2
Bennett, D.W.3
Krauss, R.M.4
-
26
-
-
0000898845
-
An analysis of variance test for normality (complete samples)
-
Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
-
(1965)
Biometrika
, vol.52
, pp. 591-611
-
-
Shapiro, S.S.1
Wilk, M.B.2
-
27
-
-
0036803259
-
Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects
-
Schaefer EJ, McNamara JR, Tayler T, et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002;90:689-96.
-
(2002)
Am J Cardiol
, vol.90
, pp. 689-696
-
-
Schaefer, E.J.1
McNamara, J.R.2
Tayler, T.3
-
28
-
-
0035897696
-
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
29
-
-
0023726344
-
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
-
Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641-51.
-
(1988)
JAMA
, vol.260
, pp. 641-651
-
-
Manninen, V.1
Elo, M.O.2
Frick, M.H.3
-
30
-
-
0035962077
-
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: A randomized controlled trial
-
Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 2001;285:1585-91.
-
(2001)
JAMA
, vol.285
, pp. 1585-1591
-
-
Robins, S.J.1
Collins, D.2
Wittes, J.T.3
-
31
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies
-
Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79:8-15.
-
(1989)
Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probstfield, J.L.2
Garrison, R.J.3
-
32
-
-
0028200951
-
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study
-
Schaefer EJ, Lamon-Fava S, Ordovas JM, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994;35:871-82.
-
(1994)
J Lipid Res
, vol.35
, pp. 871-882
-
-
Schaefer, E.J.1
Lamon-Fava, S.2
Ordovas, J.M.3
-
33
-
-
0029083670
-
Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency
-
Ikewaki K, Nishiwaki M, Sakamoto T, et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. J Clin Invest 1995;96:1573-81.
-
(1995)
J Clin Invest
, vol.96
, pp. 1573-1581
-
-
Ikewaki, K.1
Nishiwaki, M.2
Sakamoto, T.3
-
34
-
-
0029740950
-
Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
-
Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
-
(1996)
JAMA
, vol.276
, pp. 875-881
-
-
Gardner, C.D.1
Fortmann, S.P.2
Krauss, R.M.3
-
35
-
-
0031032723
-
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Québec Cardiovascular Study
-
Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation 1997;95:69-75.
-
(1997)
Circulation
, vol.95
, pp. 69-75
-
-
Lamarche, B.1
Tchernof, A.2
Moorjani, S.3
-
36
-
-
0142088521
-
Unique lipoprotein phenotype and genotype associated with exceptional longevity
-
Barzilai N, Atzmon G, Schechter C, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003;290:2030-40.
-
(2003)
JAMA
, vol.290
, pp. 2030-2040
-
-
Barzilai, N.1
Atzmon, G.2
Schechter, C.3
-
37
-
-
0037327033
-
Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis
-
Baster PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160-7.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 160-167
-
-
Baster, P.J.1
Brewer Jr., H.B.2
Chapman, M.J.3
Hennekens, C.H.4
Rader, D.J.5
Tall, A.R.6
-
38
-
-
0029948968
-
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
-
Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
-
(1996)
J Clin Invest
, vol.97
, pp. 2917-2923
-
-
Zhong, S.1
Sharp, D.S.2
Grove, J.S.3
-
39
-
-
0034061148
-
Association of cholesteryl ester transfer protein-Taq1B polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham Study
-
Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-Taq1B polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham Study. Arterioscler Thromb Vasc Biol 2000;20:1323-9.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1323-1329
-
-
Ordovas, J.M.1
Cupples, L.A.2
Corella, D.3
-
40
-
-
0036061676
-
Cholesteryl ester transfer protein Taq1 B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial
-
Brousseau ME, O'Connor JJ Jr, Ordovas JM, et al. Cholesteryl ester transfer protein Taq1 B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 2002;22:1148-54.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1148-1154
-
-
Brousseau, M.E.1
O'Connor Jr., J.J.2
Ordovas, J.M.3
|